Want to see NYMXF full AI Analyst Report?

Nymox Pharmaceutical (NYMXF) Financial Statements

145 Followers

Nymox Pharmaceutical Financial Overview

Nymox Pharmaceutical's market cap is currently $2.10M. The company's EPS TTM is $; its P/E ratio is -0.45; Nymox Pharmaceutical is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25	Dec 24	Dec 23	Mar 23	Dec 21
Income Statement
Total Revenue	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Gross Profit	$ -1.00K	$ -1.00K	$ -11.00K	$ -12.00K	$ -12.00K
Operating Income	$ -3.68M	$ -4.28M	$ -8.35M	$ -6.65M	$ -12.50M
EBITDA	$ -3.56M	$ -4.26M	$ -8.77M	$ -6.52M	$ -12.49M
Net Income	$ -4.28M	$ -4.49M	$ -8.84M	$ -6.58M	$ -12.54M
Balance Sheet
Cash & Short-Term Investments	$ 6.00K	$ 74.00K	$ 70.00K	$ 1.40M	$ 830.00K
Total Assets	$ 576.00K	$ 654.00K	$ 627.00K	$ 1.63M	$ 2.03M
Total Debt	$ 0.00	$ 0.00	$ 750.00K	$ 173.00K	$ 391.00K
Net Debt	$ -6.00K	$ -74.00K	$ 680.00K	$ -1.23M	$ -439.00K
Total Liabilities	$ 9.88M	$ 7.43M	$ 3.80M	$ 2.11M	$ 1.95M
Stockholders' Equity	$ -9.30M	$ -6.78M	$ -3.17M	$ -482.00K	$ 83.00K
Cash Flow
Free Cash Flow	$ -1.81M	$ -2.60M	$ -4.06M	$ -5.21M	$ -9.83M
Operating Cash Flow	$ -1.81M	$ -2.60M	$ -4.06M	$ -5.21M	$ -9.82M
Investing Cash Flow	$ -1.00K	$ 0.00	$ -3.00K	$ 0.00	$ -6.00K
Financing Cash Flow	$ 1.74M	$ 2.60M	$ 2.73M	$ 5.78M	$ 7.04M

Currency in USD

Nymox Pharmaceutical Earnings and Revenue History

Income Statement >

Nymox Pharmaceutical Debt to Assets

Balance Sheet >

Nymox Pharmaceutical Cash Flow

Cash Flow >

Nymox Pharmaceutical Forecast EPS vs Actual EPS

Earnings >